Benefits
Regularity and stool comfort
In a double-blind randomized trial of 132 self-reported constipated adults, 11 g/day of Biotis GOS increased stool frequency in those who started with three or fewer bowel movements per week and in adults 35 or older. Across the whole group the change was a non-significant trend, so the regularity benefit is clearest in people with genuinely low baseline frequency.
Bifidobacteria support
GOS is selectively fermented by beneficial bifidobacteria, helping shift the microbiome toward a healthier profile.
Digestive support and gut barrier
By feeding bifidobacteria and raising short-chain fatty acid production, GOS may support the gut barrier. Any effect on the gut-associated immune tissue is a proposed mechanism only: no immune outcome was measured in the trial on this ingredient.
Mechanism of action
Selective bifidogenic fermentation
Bifidobacteria preferentially ferment GOS, producing short-chain fatty acids and lowering gut pH, which favors beneficial species.
Stool bulking and hydration
As a soluble fiber, GOS draws water into the stool and adds microbial mass, supporting regularity.
Clinical trials
Double-blind randomized placebo-controlled trial of Biotis GOS (11 g or 5.5 g per day) on stool frequency and fecal microbiota. (Schoemaker et al. 2022, Nutrients)
Adults.
In 132 self-reported constipated adults, 11 g/day of Biotis GOS increased stool frequency among those with low baseline frequency (three or fewer movements per week) and adults 35 or older; the overall effect was a non-significant trend. A clear dose-response rise in fecal Bifidobacterium was seen.